B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

August 6, 2020

Intravascular large B cell lymphoma pathological findings led by positron emission tomography findings: About one case

Néphrologie & thérapeutique
Sébastien PuigrenierMarc Ulrich
August 5, 2020

LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK-eIF2α-ATF4-CHOP axis

Acta Pharmacologica Sinica
Xiao-Xuan YuHui Hui
August 7, 2020
Open Access

Novel Therapies Potentially Available for Pediatric B-Cell Non-Hodgkin Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
Paul D Harker-MurrayMatthew Barth
August 5, 2020

Surgical treatment of a primary cardiac lymphoma presenting with cardiac tamponade

General Thoracic and Cardiovascular Surgery
Juan XiaXiaojing Ma
August 5, 2020

Light-emitting diode irradiation induces AKT/mTOR-mediated apoptosis in human pancreatic cancer cells and xenograft mouse model

Journal of Cellular Physiology
Young Mi KimJi Hyeon Ryu
August 3, 2020

Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma: a retrospective study of 23 cases

International Journal of Hematology
Masuho SaburiToshiyuki Nakayama
August 4, 2020

Use of Commercial anti-CD19 CAR T Cell Therapy for Patients with Relapsed/Refractory Aggressive B Cell Lymphoma in a European center

American Journal of Hematology
Pierre SesquesEmmanuel Bachy
August 7, 2020
Open Access

Hematopoietic Progenitor Cell Transplantation in Children, Adolescents, and Young Adults With Relapsed Mature B-Cell NHL

Journal of the National Comprehensive Cancer Network : JNCCN
Aliza Gardenswartz, Mitchell S Cairo
August 1, 2020
Open Access

Inflammatory Cells in Diffuse Large B Cell Lymphoma

Journal of Clinical Medicine
Roberto TammaDomenico Ribatti
August 3, 2020
Comment / Editorial
Open Access

BCL2 dependency in diffuse large B-cell lymphoma: it's a family affair

Shannon M Matulis, Lawrence H Boise
August 2, 2020
Open Access

Landscape of DNA binding signatures of myocyte enhancer factor-2B reveals a unique interplay of base and shape readout

Nucleic Acids Research
Ana Carolina Dantas MachadoRemo Rohs
August 1, 2020

Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017

The British Journal of Ophthalmology
Frederik HolmSteffen Heegaard
August 4, 2020
Case Report
Open Access

Two cases of spindle cell variant diffuse large B-cell lymphoma of the uterine cervix

Gynecologic Oncology Reports
Hiroko MurataShoji Kamiura
August 4, 2020

Diagnostic challenge of T-cell MALT lymphoma in oral cavity

Oral Oncology
Samuel Rocha FrançaMarcelo Bonifácio da Silva Sampieri
August 2, 2020

Targeted Next Generation Sequencing Reveals Molecular Heterogeneity in non-CLL Clonal B-Cell Lymphocytosis

Hematological Oncology
Irene DefrancescoLuca Arcaini
August 4, 2020

Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy

The Journal of Molecular Diagnostics : JMD
Manuel Montesinos-RongenMartina Deckert

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman disease is rare lymphoproliferative disorder unicentric (localized) or multicentric (systemic). Discover the latest research here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

FLT3 Inhibitors in Acute Myeloid Leukemia

FMS related tyrosine kinase 3 (FLT3) is a frequently mutated receptor tyrosine kinase in Acute Myeloid Leukemia. Novel Tyrosine kinase inhibitors against FLT3 are currently in clinical trial. Discover the latest research on FLT3 Inhibitors in Acute Myeloid Leukemia here.

© 2020 Meta ULC. All rights reserved